John B. Sanfilippo & Son, Inc. JBSS 深 沪
已收盘 02-06 16:00:00 美东时间
78.61
-0.750
-0.95%
华盛通- 最 高80.96
- 今 开79.59
- 成交量 6.87万股
- 最 低 78.10
- 昨 收 79.36
- 总市值 9.19亿
- 52周最高 81.93
- 市盈率 静 15.64
- 换手率 0.59%
- 52周最低 55.97
- 委 比 -43.47%
- 总股本 1168.68万
- 历史最高 119.66
- 量 比 0.71
- 振 幅 3.60%
- 历史最低 -33.62
- 每 手 1
- 风险率 5.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 高露洁棕榄、再生元制药、伊士曼化工、威瑞森、Ameris、丘奇＆德怀特等获多家大行上调目标价
今日重点评级关注：Benchmark：维持Charter Communications"买入"评级，目标价从425美元升至455美元；BTIG：维持LifeStance Health Gr"买入"评级，目标价从10美元升至11美元
02-03 09:06
BWS Financial Maintains Buy on John B Sanfilippo & Son, Maintains $109 Price Target
BWS Financial analyst Hamed Khorsand maintains John B Sanfilippo & Son (NASDAQ:JBSS) with a Buy and maintains $109 price target.
02-03 04:39
Earnings Scheduled For January 29, 2026
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
John B Sanfilippo & Son's Earnings Outlook
John B Sanfilippo & Son (NASDAQ:JBSS) will release its quarterly earnings r...
01-29 05:02
Adecoagro's Earnings: A Preview
Adecoagro (NYSE:AGRO) is set to give its latest quarterly earnings report on Tu...
2025-11-10 22:03
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
John B. Sanfilippo & Son Declares Special Dividend Of $1/Share
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced that its Board of Directors (the "Board") declared a special cash dividend (the "Special Dividend") of $1.00 per share on all issued and
2025-10-30 04:26
John B Sanfilippo & Son Q1 EPS $1.59 Beats $1.28 Estimate, Sales $298.683M Beat $273.925M Estimate
John B Sanfilippo & Son (NASDAQ:JBSS) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $1.28 by 24.22 percent. This is a 59 percent increase over earnings of $1.00 per share
2025-10-30 04:12
Exploring John B Sanfilippo & Son's Earnings Expectations
John B Sanfilippo & Son (NASDAQ:JBSS) will release its quarterly earnings r...
2025-10-29 05:03
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
2025-09-23 09:52
